Allworth Financial LP - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 217 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2020. The put-call ratio across all filers is 0.91 and the average weighting 0.3%.

Quarter-by-quarter ownership
Allworth Financial LP ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q2 2024$460
+21.1%
40.0%0.00%
Q1 2024$380
+3.0%
40.0%0.00%
Q4 2023$369
+265.3%
4
+100.0%
0.00%
Q3 2023$101
-80.0%
2
-75.0%
0.00%
Q2 2023$506
-96.1%
8
-95.9%
0.00%
Q3 2022$13,000193
+4725.0%
0.00%
Q1 2022$0
-100.0%
4
-98.8%
0.00%
-100.0%
Q4 2019$27,0003410.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q1 2020
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 559,381$41,098,00015.69%
Casdin Capital, LLC 940,000$69,061,800,0007.15%
Ghost Tree Capital, LLC 325,000$23,878,0006.08%
CADIAN CAPITAL MANAGEMENT, LP 1,418,704$104,232,0004.96%
DAFNA Capital Management LLC 123,218$9,053,0003.40%
BVF INC/IL 437,565$32,148,0003.38%
Opaleye Management Inc. 105,000$7,714,0002.79%
Cormorant Asset Management, LP 493,000$36,221,0002.20%
Novo Holdings A/S 170,667$12,539,0002.15%
Artal Group S.A. 600,000$44,082,0001.77%
View complete list of BLUEPRINT MEDICINES CORP shareholders